Enliven Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ELVN and other ETFs, options, and stocks.

About ELVN

Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of small molecule therapeutics. Its pipeline includes BCR-ABL Program: ELVN-001and HER2 Program: ELVN-002. 

CEO
Richard A. Fair
CEORichard A. Fair
Employees
60
Employees60
Headquarters
Boulder, Colorado
HeadquartersBoulder, Colorado
Founded
2019
Founded2019
Employees
60
Employees60

ELVN Key Statistics

Market cap
1.75B
Market cap1.75B
Price-Earnings ratio
-16.24
Price-Earnings ratio-16.24
Dividend yield
Dividend yield
Average volume
778.31K
Average volume778.31K
High today
$30.20
High today$30.20
Low today
$28.61
Low today$28.61
Open price
$29.43
Open price$29.43
Volume
752.96K
Volume752.96K
52 Week high
$30.63
52 Week high$30.63
52 Week low
$13.30
52 Week low$13.30

Stock Snapshot

Enliven Therapeutics(ELVN) stock is priced at $29.29, giving the company a market capitalization of 1.75B. It carries a P/E multiple of -16.24.

As of 2026-03-05, Enliven Therapeutics(ELVN) stock has fluctuated between $28.61 and $30.20. The current price stands at $29.29, placing the stock +2.4% above today's low and -3.0% off the high.

Enliven Therapeutics(ELVN) shares are trading with a volume of 752.96K, against a daily average of 778.31K.

In the last year, Enliven Therapeutics(ELVN) shares hit a 52-week high of $30.63 and a 52-week low of $13.30.

In the last year, Enliven Therapeutics(ELVN) shares hit a 52-week high of $30.63 and a 52-week low of $13.30.

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own ELVN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.